Abterra Bio News

Stay updated on all things Abterra Bio. Includes scientific and company updates.

Clonal Hit-Expansion Case Study

Jun 6, 2021 | Science, Services

Abterra Bio uses next-generation sequencing to mine the clonal lineage of serum-identified antibodies. This method rescues relatives of hits that are within a clone and increases diversity in your antibody discovery campaign. 

Contact us to learn more about how our hit expansion service can help you reduce wasted effort on analysis of identical candidates.


Tell Us About Your Project

Related Resources

Watch the full presentation, Next-Generation Repertoire Sequencing for Mining Single Domain Antibodies, that was given by our CSO, Stefano Bonissone, at the PEGS Boston Virtual Summit 2021.

Read more on our major findings from a recent Alicanto’s analysis of the llama immune response to immunization.